Devicemakers slow to embrace social media; Companies race to develop bionic eye;

 @FierceMedDev: Sonitus turns to Europe for the commercial rollout of its new hearing aid. It transmits sound through teeth. Release | Follow @FierceMedDev

 @MarkHFierce: Whites are more likely to be treated with CRT-D therapy than blacks and Hispanics, according to a new study. Article | Follow @MarkHFierce

 @DamianFierce: Hologic has to fork over $4M after losing a patent suit to Smith & Nephew. News | Follow @DamianFierce

> Medical device companies have been slow to embrace social media compared to other biotechs, with fewer than half the firms surveyed by Frost & Sullivan having any social media presence. Article

> SinuSys got a CE mark for the AerOs sinus dilation system, designed to open the sinus ostia to restore drainage and ventilation. News

> Bloomberg takes a look at the race to develop a bionic eye to help the world's 285 million blindness sufferers. Article

> Vertos Medical is squabbling with a doctor who, after administering a trial for a back pain-treating device, followed up with patients on his own and reported that the tech had failed them. Story

> Devicemaker Nordion reported net income of $12.3 million in its third quarter, a boost over the $4.1 million loss the company took in the same period last year. Item

> Germany's aap Implantate got 510(k) clearance for the small fragment plating line of its Loqteq trauma plating system. Release

> Continuing its campaign to cut back on how much radiation patients are exposed to, GE Healthcare ($GE) has partnered with Advocate Health Care to install its DoseWatch software for CT scans performed by the health system. More

Biotech News

 @FierceBiotech: HGS sharpens ax as restructuring claims 114 jobs. Item | Follow @FierceBiotech

 @JohnCFierce: Five down (as in 5 straight late-stage failures): Another Eli Lilly drug flunks a Phase III test. Article | Follow @JohnCFierce

> Zymeworks snags $11M, Merck milestone to fuel bi-specific antibody work. More

> Tufts: Cancer drugs win a speedier race to the FDA goal line. Story

> Merck KGaA grabs a cancer antibody hybrid in $625M Symphogen pact. News

Pharma News

 @FiercePharma: Jazz Pharma is selling its women's health business to Meda for $95M; 60 jobs to go along--APNews | Follow @FiercePharma

> Top Warner Chilcott investors to unload 43M shares. Article

> Public Citizen sues FDA over Aricept safety. News

> New Indian price caps would raise another hurdle to Big Pharma. Story

Vaccines News

> University of Oklahoma advances work on West Nile vaccine. Item

> Low HPV vaccination rates spur calls for wider use. Article

> Dendritic cells raise questions about cancer vax effectiveness. More

> ImmusanT launches U.S. trial for celiac vax. News

Pharma Manufacturing News

> Sun recalls biosimilar used for treating brain bleeding. More

> Under regulatory cloud, CEO says Novartis must boost quality. Article

> Competitors' manufacturing screw-ups keep Fresenius busy. Story

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.